In conclusion, our findings revealed that UKT decreased estrous cycle abnormalities and increased follicular development in PCOS rat models by potentiating FSH responsiveness, which was mediated by the upregulation of BMP-2 and BMP-6 expressions. Here, BRD2 is linked to polycystic ovary syndrome.